QUALITY OF LIFE IN GLAUCOMA KVALITET ŽIVOTA KOD GLAUKOMA
Sažetak
Abstract
Glaucoma is a progressive neurodegenerative disease that can lead to irreversible blindness, if left untreated. There are different modalities in glaucoma treatment, but the most common include using local hypotensive eye drops. Due to the visual impairment or the use of glaucoma medication, people with glaucoma often report different difficulties in everyday life. Simple exams and assessments of clinical glaucoma parameters (like visual field) are not sufficient to describe patients’ problems and needs. Therefore, the investigation of their quality of life (QOL) is indispensable in management of glaucoma patients. Quality of life in people with glaucoma is usually decreased and typically physical, psychological and social aspects are affected. Quality of life is usually evaluated with the use of patient reported outcome measures (PRO) and the most used form of PRO is questionnaire. Recently, two of the glaucoma specific questionnaires - Glaucoma Quality of life-15 and Glaucoma Symptom Scale – have been validated in the Serbian language and are available for use in glaucoma populations. The main goal of glaucoma management should be preserving patients’ vision while keeping and improving their quality of life, which is the reason why QOL assessments are of a great importance in glaucoma.
Keywords: glaucoma, quality of life, glaucoma specific questionnaires
Sažetak
Glaukom je progresivno neurodegenerativno oboljenje koje, ukoliko se ne leči, može da dovede do potpunog slepila. Postoje različiti terapijski pristupi u lečenju glaukoma, pri čemu je najčešći oblik terapije primena lokalne hipotenzivne terapije u vidu kapi. Osobe sa glaukomom često navode različite probleme u svakodnevnom funkcionisanju. Osnovni pregled i procena kliničkih parametara vezanih za glaukom (npr. vidno polje) ne mogu u potpunosti da opišu sve poteškoće i potrebe sa kojima se suočavaju osobe sa glaukomom. Stoga je procena kvaliteta života nezaobilazna stavka u praćenju osoba obolelih od ove bolesti. Kvalitet života kod ovih osoba obično je narušen i to posebno njegovi fizički, psihološki i socijalni aspekti. Procena kvaliteta života se obično vrši uz pomoć merila pacijentovog prikaza ishoda (engl. patient reported outcome measures). Najčešći oblik merila su upitnici. Dva upitnika za glaukom su validirana i dostupna na srpskom jeziku: Kvalitet života kod glaukoma 15 (engl. Glaucoma Quality of life-15) i Skala simptoma kod glaukoma (engl. Glaucoma Symptom Scale). Ispitivanje kvaliteta života kod glaukoma od velike je važnosti budući da glavni princip lečenja ovih osoba predstavlja očuvanje postojećeg vida, uz održavanje i poboljšanje njihovog kvaliteta života.
Ključne reči: glaukom, kvalitet života, glaukom specifični upitnici
Reference
Labiris G, Katsanos A, Fanariotis M, Zacharaki F, Chatzoulis D, Kozobolis VP. Vision-specific Quality of Life in Greek Glaucoma Patients. J Glaucoma. 2010; 19(1):39-43.
European Glaucoma Society. European Glaucoma Society Guidelines (2014): Terminology and Guidelines for Glaucoma. 4th ed. Savona, Italy: PubliComm; 2014; 79-139.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90(3): 262–267.
Golubovic S. Oftalmologija: udžbenik za studente medicine. Prvo izdanje. Medicinski fakultet Univerziteta u Beogradu, Libri Medicorum; 2010.
Weinreb RN. Glaucoma worldwide: A growing concern. Glaucoma Research Foundation. Gleams 2008.
Janz NK, Wren PA, Lichter PR, Musch DC, Gillespie BW, Guire KE, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001; 108(11): 1954–1965.
Lee DA, Higginbotham EJ. Glaucoma and its treatment: a review. Am J Health Syst Pharm. 2005; 62(7): 691–699.
Day AC, Baio G, Gazzard G, Bunce C, Azuara-Blanco A, Munoz B, Friedman DS, Foster PJ. The prevalence of primary angle closure glaucoma in European derived populations: a systematic review. Br J Ophthalmol. 2012;96(9):1162-7.
Kulkarni SV, Damji KF, Buys YM. Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency. Patient Prefer Adherence. 2008;2:303-314.
Rossi GC, Tinelli C, Pasinetti GM, Milano G, Bianchi PE. Dry eye syndrome-related quality of life in glaucoma patients. Eur J Ophthalmol. 2009;19: 572–579.
Atkinson MJ, Stewart WC, Fain JM, Stewart JA, Dhawan R, Mozaffari E, Lohs J. A new measure of patient satisfaction with ocular hypotensive medications: The treatment satisfaction survey for intraocular pressure (TSS-IOP). Health Qual Life Outcomes. 2003;1:67.
Quaranta L, Riva I, Gerardi C, Oddone F, Floriano I, Konstas AG. Quality of life in glaucoma: a review of the literature. Adv Ther. 2016;33: 959-981.
Spaeth G, Walt J, Keener J. Evaluation of quality of life for patients with glaucoma. Am J Ophthalmol. 2006;141: S3-S14.
Division of Mental Health and Prevention of Substance Abuse WHO. Measuring quality of life. 1997. http://www.who.int/mental_health/media/68.pdf. Accessed 1 Apr 2019.
Felce D, Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995;16:51–74.
Nirmalan PK, Tielsch JM, Katz J, Thulasiraj RD, Krishnadas R, et al. Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci. 2005;46:2308–12.
Ivers RQ, Cumming RG, Mitchell P, Attebo K. Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc. 1998;46:58–64.
Ribeiro MV, Hasten-Reiter Junior HN, Ribeiro EA, Juca MJ, Barbose FT, Sousa-Rodrigues CF. Association between visual impairment and depression in the elderly: a systematic review. Arq Bras Oftalmol. 2015;78:197–201.
McGwin G Jr, Xie A, Mays A, Joiner W, DeCarlo DK, Hall TA, et al. Visual field defects and the risk of motor vehicle collisions among patients with glaucoma. Invest Ophthalmol Vis Sci. 2005;46:4437–41.
Gutierrez P, Wilson MR, Johnson C, Gordon M, Cioffi GA, Ritch R, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115:777-784.
Mabuchi F, Yoshimura K, Kashiwagi K, Shioe K, Yamagata Z, Kanba S, et al. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma. 2008;17:552–7.
Jampel HD, Frick KD, Janz NK, Wren PA, Musch DC, Rimal R, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144:238–44.
Agorastos A, Skevas C, Matthaei M, Otte C, Klemm M, Richard G, et al. Depression, anxiety, and disturbed sleep in glaucoma. J Neuropsychiatry Clin Neurosci. 2013;25:205–13.
Ramulu P. Glaucoma and disability: Which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol. 2009; 20(2):92-98.
Janz NK, Wren PA, Lichter PR, Musch DC, Gillespie BW, Guire KE. Quality of life in newly diagnosed glaucoma patients: The collaborative initial glaucoma treatment study. Ophthalmology. 2001;108(5):887-897.
Lester M, Zingirian M. Quality of life in patients with early, moderate and advanced glaucoma. Eye. 2002;16(1):44-49.
Rossi GC, Tinelli C, Pasinetti GM, Milano G, Bianchi PE. Dry eye syndrome-related quality of life in glaucoma patients. Eur J Ophthalmol. 2009;19:572–579.
Atkinson MJ, Stewart WC, Fain JM, Stewart JA, Dhawan R, Mozaffari E, Lohs J. A new measure of patient satisfaction with ocular hypotensive medications: The treatment satisfaction survey for intraocular pressure (TSS-IOP). Health Qual Life Outcomes. 2003;1:67.
Nordmann JP, Auzanneau N, Ricard S, Berdeaux G. Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes. 2003;1:75.
Kulkarni SV, Damji KF, Buys YM. Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency. Patient Prefer Adherence. 2008;2:303-314.
Kaur J, Gupta A, Singh G. Perspectives on Quality of Life in Glaucoma. J Curr Glaucoma Prac. 2012; 6(1): 9-12.
Vandenbroeck S, De Geest S, Zeyen T, Stalmqns I, Dobbels F. Patient-reported outcomes (PRO’s) in glaucoma: a systematic review. Eye. 2011: 25; 555-577.
Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess. 1998; 2(14): i–74.
Spratt A, Kotecha A, Viswanathan A. Quality of Life in Glaucoma. J Curr Glaucoma Pract. 2008; 2:39-45.
Van Gestel A, Webers C, Beckers H, Van Dongen M, Severens J, Hendrikse F, et al. The relationship between visual field loss in glaucoma and health-related quality of life. 2010:
; 1759-1769.
Sencanic I, Gazibara T, Dotlic J, Stamenkovic M, Jaksic V, Bozic M, et al. Glaucoma Symptom Scale: Psychometric properties of the Serbian version. PLoS One. 2019 May
;14(5):e0216920.
Sencanic I, Gazibara T, Dotlic J, Stamenkovic M, Jaksic V,
Bozic M, et al. Validation of the Glaucoma Quality of Life-15 Questionnaire in Serbian language. Int J Ophthalmol. 2018; 11: 1674-1684.
Lee BL, Gutierrez P, Gordon M, Wilson MR, Cioffi GA, Ritch R, et al. The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms. Arch Ophthalmol. 1998;116: 861-866.
Nelson P, Aspinall P, Papasouliotis O, Worton B, O’Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma. 2003;12:139-150.